These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34063475)

  • 1. Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer.
    Kaban K; Hinterleitner C; Zhou Y; Salva E; Kantarci AG; Salih HR; Märklin M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34063475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer.
    Hashemi ZS; Ghavami M; Kiaie SH; Mohammadi F; Barough MS; Khalili S; Hosseini-Farjam Z; Mossahebi-Mohammadi M; Sheidary A; Ghavamzadeh A; Forooshani RS
    Nanomedicine (Lond); 2023 Feb; 18(5):437-453. PubMed ID: 37199259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural killer cell-derived exosome-entrapped paclitaxel can enhance its anti-tumor effect.
    Han D; Wang K; Zhang T; Gao GC; Xu H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5703-5713. PubMed ID: 32495906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer.
    Tekedereli I; Alpay SN; Akar U; Yuca E; Ayugo-Rodriguez C; Han HD; Sood AK; Lopez-Berestein G; Ozpolat B
    Mol Ther Nucleic Acids; 2013 Sep; 2(9):e121. PubMed ID: 24022053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
    Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Front Immunol; 2018; 9():824. PubMed ID: 29740437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy.
    Wang G; Hu W; Chen H; Shou X; Ye T; Xu Y
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
    Huang MB; Gonzalez RR; Lillard J; Bond VC
    Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells.
    Zhu L; Gangadaran P; Kalimuthu S; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S166-S179. PubMed ID: 30092165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.
    Song RX; Zhang Z; Mor G; Santen RJ
    Apoptosis; 2005 May; 10(3):667-78. PubMed ID: 15909128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Delivery of Electrostatically Complexed Multiple Gene-Targeting siRNAs and an Anticancer Drug for Synergistically Enhanced Treatment of Prostate Cancer.
    Choi E; Yoo W; Park JH; Kim S
    Mol Pharm; 2018 Sep; 15(9):3777-3785. PubMed ID: 30028622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Exosomes for Targeted Transfer of siRNA to HER2 Positive Breast Cancer Cells.
    Limoni SK; Moghadam MF; Moazzeni SM; Gomari H; Salimi F
    Appl Biochem Biotechnol; 2019 Jan; 187(1):352-364. PubMed ID: 29951961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction.
    Uherek C; Tonn T; Uherek B; Becker S; Schnierle B; Klingemann HG; Wels W
    Blood; 2002 Aug; 100(4):1265-73. PubMed ID: 12149207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
    Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
    Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression.
    Ma Z; Luo Y; Qiu M
    Med Sci Monit; 2017 Jan; 23():359-365. PubMed ID: 28109198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
    Thapa B; Bahadur Kc R; Uludağ H
    Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β2-microglobulin has a different regulatory molecular mechanism between ER
    Chai D; Li K; Du H; Yang S; Yang R; Xu Y; Lian X
    BMC Cancer; 2019 Mar; 19(1):223. PubMed ID: 30866857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Fusion-Mediated Loading of Therapeutic siRNA into Exosome for Tissue-Specific Application.
    Xie M; Wu Y; Zhang Y; Lu R; Zhai Z; Huang Y; Wang F; Xin C; Rong G; Zhao C; Jiang K; Zhou X; Zhou X; Zhu X; Hong J; Zhang C
    Adv Mater; 2024 Jun; ():e2403935. PubMed ID: 38889294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
    Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
    BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
    Kumar R; Mandal M; Lipton A; Harvey H; Thompson CB
    Clin Cancer Res; 1996 Jul; 2(7):1215-9. PubMed ID: 9816290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.